Behçet's disease is a chronic multisystem disorder characterized by relapsing inflammation
for which the underlying histopathology is an occlusive vasculitis. The disease has a high …

The TNF-α inhibitors adalimumab and infliximab have the greatest body of data supporting
their use in NIU. These agents are considered second-line therapy for most forms of NIU but …

Abstract Background Qinghuo Rougan Formula (QHRGF) is a traditional Chinese medicine
(TCM) that has been widely apllied to treat uveitis for several decades. However, the …

Non-infectious uveitis are intraocular inflammatory conditions caused by dysregulated
activation of the immune response without any detectable infectious agents. The aim of this …

Behçet's disease is a systemic vasculitis that affects multiple organs. The most common
manifestations are oral and genital ulcerations and recurrent uveitis. Uveitis can be an initial …

Exudative retinal detachment develops when fluid collects in the subretinal space. The
subretinal space between the photoreceptors and the retinal pigment epithelium is the …

During the last decades the efficacy of biologic agents, mainly of anti-TNFs, in controlling the
activity of serious manifestations of Behcet's Disease (BD) has been established. On the …

Behçet disease (BD) is a serious, systemic disorder characterized by recurrent bouts of
inflammation. 1-4 Over two-thirds of patients with BD will develop ocular inflammation-most …

Described as early as Hippocrates in his “Third Book of Endemic Diseases,” Behçet's
Disease (BD), also known as “The Silk Road Disease” following its initial demographics …

Purpose: To evaluate and compare the efficacy and safety of interferon alpha-2a (IFN-α2a)
and cyclosporine-A (CsA) in patients with refractory Behçet's uveitis (BU). Methods: In this 12 …